Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Michael Jordan, Franco Locatelli, Didier Halimi, Elena Burillo, Brian Jamieson, Andrew Danquah, Emmanuel Monnet

Blood (2025) 146 (Supplement 1): 4758.

https://doi.org/10.1182/blood-2025-4758

Published: 2025

Journal Articles

Use of emapalumab is associated with rapid and sustained benefits in primary HLH subgroups, including CNS involvement and previously untreated patients: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Franco Locatelli, Michael Jordan, Didier Halimi, Elena Burillo, Brian Jamieson, Emmanuel Monnet, Andrew Danquah

Blood (2025) 146 (Supplement 1): 2979.

https://doi.org/10.1182/blood-2025-2979

Published: 2025

Journal Articles

Patients (pts) with Optimized Hemophagocytic Lymphohistiocytosis (HLH) Inflammatory (OHI) Index-Confirmed Diagnosis of Malignancy-Associated HLH (mHLH) and Emapalumab Treatment

Naval Daver, Andrew Danquah, Didier Halimi, Jérôme Wojcik, Emmanuel Monnet

Blood (2024) 144 (Supplement 1): 3913.

https://doi.org/10.1182/blood-2024-199835

Published: 2024